In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm. Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene has probably seen more than most in drug development!
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gene, speaking on the transformation of the CDMO landscape over the last 30 years. They  address the many changes that have occurred but also the things that have stayed the same as time goes on. They also discuss the benefit of truly ‘value-add’ CDMOs to small and large drug developers in helping achieve pipeline success and raising the CDMO bar. Lastly Gene discusses the importance of being okay with making mistakes and addresses trust and integrity as two key pillars in the heavily regulated pharmaceutical and biotech drug development space.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.